Viatris Eye Drops Data Shows Promise For Blurred Near Vision

benzinga.com/news/health-care/25/06/46121861/viatris-eye-drops-data-shows-promise-for-blurred-near-vision

Viatris Inc. (NASDAQ:VTRS) and Opus Genetics, Inc. (NASDAQ:IRD) revealed topline results from VEGA-3, the second pivotal Phase 3 trial evaluating MR-141 (phentolamine ophthalmic solution 0.75%) for presbyopia.
Presbyopia is the gradual loss of near-focusing ability due to aging that…

This story appeared on benzinga.com, 2025-06-26 17:07:47.
The Entire Business World on a Single Page. Free to Use →